International Biotechnology Trust (LSE:IBT) OCF Margin %: 7.60% (As of Feb. 2026)


LSE:IBT International Biotechnology Trust PLC LSE:IBT
32 GF Score
Price £10.50
! 4 Warning Signs
View Full Analysis

What is International Biotechnology Trust OCF Margin %?

International Biotechnology Trust LSE:IBT +1.94% 32 OCF Margin % is 7.60% as of Feb. 2026. GuruFocus rates LSE:IBT with a GF Score™ of 32/100. The stock has 4 warning signs investors should review. Among 959 Biotechnology companies, International Biotechnology Trust ranks better than 95.31% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. International Biotechnology Trust's Cash Flow from Operations for the six months ended in Feb. 2026 was £6.52 Mil. International Biotechnology Trust's Revenue for the six months ended in Feb. 2026 was £85.74 Mil. Therefore, International Biotechnology Trust's OCF Margin % for the quarter that ended in Feb. 2026 was 7.60%.

As of today, International Biotechnology Trust's current OCF Yield % is 11.96%.

The historical rank and industry rank for International Biotechnology Trust's OCF Margin % or its related term are showing as below:

LSE:IBT' s OCF Margin % Range Over the Past 10 Years
Min: -16361.71   Med: -11.41   Max: 321.39
Current: 48.81

During the past 13 years, the highest OCF Margin % of International Biotechnology Trust was 321.39%. The lowest was -16361.71%. And the median was -11.41%.

LSE:IBT's OCF Margin % is ranked better than
95.31% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs LSE:IBT: 48.81

International Biotechnology Trust OCF Margin % Related Terms

International Biotechnology Trust OCF Margin % Historical Data

* Premium members only.

The historical data trend for International Biotechnology Trust's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

International Biotechnology Trust OCF Margin % Chart

International Biotechnology Trust Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -49.90 -5.33 321.39 112.98 -16,361.71

International Biotechnology Trust Semi-Annual Data
Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 87.70 179.83 -38.74 -408.46 7.60

LSE:IBT vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, International Biotechnology Trust's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

International Biotechnology Trust OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, International Biotechnology Trust's OCF Margin % distribution charts can be found below:

* The bar in red indicates where International Biotechnology Trust's OCF Margin % falls into.


LSE:IBT
32GF Score
International Biotechnology Trust PLC LSE:IBT
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

International Biotechnology Trust OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

International Biotechnology Trust's OCF Margin for the fiscal year that ended in Aug. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Aug. 2025 )/Revenue (A: Aug. 2025 )
=28.633/-0.175
=-16,361.71 %

International Biotechnology Trust's OCF Margin for the quarter that ended in Feb. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Feb. 2026 )/Revenue (Q: Feb. 2026 )
=6.517/85.739
=7.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 7.60% mean?
International Biotechnology Trust (LSE:IBT) has a OCF Margin % of 7.60% as of Feb. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on International Biotechnology Trust and its competitors. According to the industry distribution chart, International Biotechnology Trust ranks #45 out of 959 companies in the Biotechnology industry, placing it in the top 4.7%.
Is International Biotechnology Trust's OCF Margin % too high?
International Biotechnology Trust's current OCF Margin % is 7.60%. Based on the distribution chart, International Biotechnology Trust ranks #45 out of 959 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, International Biotechnology Trust has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does International Biotechnology Trust's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, International Biotechnology Trust ranks #45 out of 959 companies for OCF Margin %. This places International Biotechnology Trust in the top 5% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on International Biotechnology Trust and its competitors. International Biotechnology Trust's current OCF Margin % is 7.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is International Biotechnology Trust stock overvalued right now?
International Biotechnology Trust (LSE:IBT) has a current OCF Margin % of 7.60%. The current OCF Margin % is 7.60%. International Biotechnology Trust's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For International Biotechnology Trust (LSE:IBT), the current OCF Margin % is 7.60% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

International Biotechnology Trust Business Description

Address 1 London Wall Place, London, GBR, EC2Y 5AU
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments ,and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.
32GF Score

Get the complete analysis for LSE:IBT

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£10.50
Price